Materials Healthcare Sector

Matinas BioPharma Holdings

Market Cap: US$3.9m

A clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology.

Mosaic ImmunoEngineering

Market Cap: US$3.9m

A development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer.

Mitesco

Market Cap: US$3.9m

Provides cloud computing, application hosting, and other data center related applications.

ProtoKinetix

Market Cap: US$3.9m

A research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs).

Adherium

Market Cap: AU$6.1m

Develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America.

Galecto

Market Cap: US$3.9m

A clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases.

GlucoTrack

Market Cap: US$3.8m

A medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States.

Kazia Therapeutics

Market Cap: US$3.8m

Operates as an oncology-focused biotechnology company in South Korea.

Totally

Market Cap: UK£2.8m

Provides healthcare services in the United Kingdom and Ireland.

Premier Health of America

Market Cap: CA$5.3m

Engages in the provision of staffing and outsourced service solutions for healthcare needs in Canada.

Sonnet BioTherapeutics Holdings

Market Cap: US$3.8m

A biotechnology company, owns a platform for biologic medicines of single or bifunctional action.

Mustang Bio

Market Cap: US$3.7m

A clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases.

MYND Life Sciences

Market Cap: CA$5.2m

A life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States.

BSF Enterprise

Market Cap: UK£2.8m

Develops and commercializes cutting-edge tissue-engineered solutions.

Uscom

Market Cap: AU$5.8m

Designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe.

bioAffinity Technologies

Market Cap: US$3.7m

Engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States.

Rua Bioscience

Market Cap: NZ$6.3m

Engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally.

Kineta

Market Cap: US$3.7m

A clinical-stage biotechnology company, engages in developing immunotherapies that transform patients’ lives in the United States.

Interpace Biosciences

Market Cap: US$3.7m

Provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States.

XORTX Therapeutics

Market Cap: CA$5.1m

A late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease.

Willow Biosciences

Market Cap: CA$5.1m

Willow Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States.

Avricore Health

Market Cap: CA$5.1m

Engages in the health data and point-of-care technologies business in Canada.

HeartSciences

Market Cap: US$3.6m

A medical technology company, focuses on applying AI-based technology to an ECG to enhance its clinical utility.

StageZero Life Sciences

Market Cap: CA$4.9m

A vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe.

CTT Pharmaceutical Holdings

Market Cap: US$3.6m

Engages in the development of oral drug delivery systems for pain management and treatment.

FinCanna Capital

Market Cap: CA$5.0m

Does not have significant operations.

Leveljump Healthcare

Market Cap: CA$4.8m

Provides radiology services.

Ayurcann Holdings

Market Cap: CA$4.9m

Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.

Genetic Technologies

Market Cap: AU$5.7m

A molecular diagnostics company, engages in the provision of predictive genetic testing and risk assessment tools to help physicians manage people’s health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

NovaBay Pharmaceuticals

Market Cap: US$3.5m

Does not have significant operations.

SciSparc

Market Cap: US$3.4m

A clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies.

VivoSim Labs

Market Cap: US$3.4m

A biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease.

InhaleRx

Market Cap: AU$5.3m

A biotechnology company, develops and sells registrable inhaled drug-device combinations in Australia.

iCoreConnect

Market Cap: US$3.4m

A cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States.

Global Health

Market Cap: AU$5.3m

Provides digital health solutions for the healthcare industry in Australia.

CNS Pharmaceuticals

Market Cap: US$3.4m

A clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors.